Sign up to save your podcasts
Or
Share Updates from the SELECT Trial: Outcomes by Sex | ESC 2024
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Updates from the SELECT Trial: Outcomes by Sex | ESC 2024
Neha J. Pagidipati, MD, FACC, JACC Associate Editor and Subodh Verma MD, PhD explore a secondary analysis of the SELECT trial, a landmark study investigating the cardiovascular benefits of semaglutide in people with obesity or overweight without diabetes.
View all episodes
By American College of Cardiology
4.2
162162 ratings
Neha J. Pagidipati, MD, FACC, JACC Associate Editor and Subodh Verma MD, PhD explore a secondary analysis of the SELECT trial, a landmark study investigating the cardiovascular benefits of semaglutide in people with obesity or overweight without diabetes.
More shows like JACC This Week
View all
JAMA Editors' Summary
138 Listeners
NEJM This Week
320 Listeners
JAMA Clinical Reviews
500 Listeners
This Week in Cardiology
899 Listeners
JACC Specialty Journals
19 Listeners
Circulation on the Run
32 Listeners
The Curbsiders Internal Medicine Podcast
3,376 Listeners
Eagle's Eye View: Your Weekly CV Update From ACC.org
136 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
62 Listeners
ACC CardiaCast
39 Listeners
Annals On Call Podcast
196 Listeners
JAMA Medical News
91 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Cardionerds: A Cardiology Podcast
431 Listeners